Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
16.02.24
/
50%
€316.20
Target price
16.02.25
€445.58
Performance (%)
-8.06%
Price
12.09.24
€290.70
Summary
This prediction is currently active. With a performance of -8.06%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 16.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bio-Rad Labs Inc. A | -2.286% | -2.286% |
iShares Core DAX® | 2.275% | 4.627% |
iShares Nasdaq 100 | 6.015% | 2.007% |
iShares Nikkei 225® | 4.456% | 3.598% |
iShares S&P 500 | 4.061% | 2.876% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Royal Bank of Canada from $484.00 to $480.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€292.30
16.08.24
16.08.24
€364.63
16.08.25
16.08.25
-1.47%
12.09.24
12.09.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€307.80
02.08.24
02.08.24
€367.36
02.08.25
02.08.25
-5.56%
12.09.24
12.09.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€363.40
04.08.23
04.08.23
€474.64
04.08.24
04.08.24
-17.06%
05.08.24
05.08.24